The novel anticonvulsant MK-801: a potent and specific ligand of the brain phencyclidine/gd-receptor

Ratna Sircar, Michael Rappaport, Roxanne Nichtenhauser, Stephan R. Zukin

Research output: Contribution to journalArticle

Abstract

MK-801 (5-methyl-10, 11-dihydro-5H-dibenzo[a,d]cyclohepten-5, 10-imine maleate) is a novel anticonvulsant agent reported to antagonize certain N-methyl-spd-aspartate (NMDA)-mediated effects non-competitively. The question arises of the mechanism underlying the anti-NMDA and anticonvulsant effects of MK-801. In the present study MK-801 is shown to be an extremely potent inhibitor of the binding of N-[3H](1-[2-thienyl]cyclohexy)piperidine) ([s3H]TCP to brain phencyclidine (PCP)/δ-receptors. It is IC5) value of 3.8 ± 0.8 nM in this assay ranks it as the most potent known ligand of brain PCP/δ-receptors. Addition of MK-801 altered the apparent Kd but not the apparent Bmax values for [3H]TCP binding, indicating a competitive interaction. The specificity of action of MK-801 is supported by the finding that MK-801 strongly inhibited the binding of (+)-N-[3H]allylnormetazocine ((+)-[3H]SKF 10.047) to the PCP/δ-receptor but its effect on (+)-[3H]SKF 10.047 binding to the non-PCP, haloperidol-sensitive δ-binding site was weaker by several orders of magnitude. Furthermore, MK-801 exerts PCP-like antagonistic effects upon NMDA-induced [3H]norepinephrine release. These findings support the concept that the anticonvulsant and anti-NMDA effects of MK-801 result from its being the most potent known ligand of PCP/δ-receptors.

Original languageEnglish (US)
Pages (from-to)235-240
Number of pages6
JournalBrain Research
Volume435
Issue number1-2
DOIs
StatePublished - Dec 1 1987
Externally publishedYes

Fingerprint

Phencyclidine Receptors
Dizocilpine Maleate
Anticonvulsants
Ligands
Brain
Aspartic Acid
Imines
Haloperidol
Norepinephrine
Binding Sites

Keywords

  • (+)-[H]SKF 10,047 competition
  • Anticonvulsant
  • Haloperidol-sensitive non-PCP/δ-binding site
  • MK-801
  • N-Methyl-d-aspartate (NMDA)-stimulated [H]norepinephrine release
  • Phencyclidine (PCP)/δ-receptor
  • [H]TCP binding

ASJC Scopus subject areas

  • Developmental Biology
  • Molecular Biology
  • Clinical Neurology
  • Neuroscience(all)

Cite this

The novel anticonvulsant MK-801 : a potent and specific ligand of the brain phencyclidine/gd-receptor. / Sircar, Ratna; Rappaport, Michael; Nichtenhauser, Roxanne; Zukin, Stephan R.

In: Brain Research, Vol. 435, No. 1-2, 01.12.1987, p. 235-240.

Research output: Contribution to journalArticle

Sircar, Ratna ; Rappaport, Michael ; Nichtenhauser, Roxanne ; Zukin, Stephan R. / The novel anticonvulsant MK-801 : a potent and specific ligand of the brain phencyclidine/gd-receptor. In: Brain Research. 1987 ; Vol. 435, No. 1-2. pp. 235-240.
@article{ddb26148baef47caa712039b247bcf16,
title = "The novel anticonvulsant MK-801: a potent and specific ligand of the brain phencyclidine/gd-receptor",
abstract = "MK-801 (5-methyl-10, 11-dihydro-5H-dibenzo[a,d]cyclohepten-5, 10-imine maleate) is a novel anticonvulsant agent reported to antagonize certain N-methyl-spd-aspartate (NMDA)-mediated effects non-competitively. The question arises of the mechanism underlying the anti-NMDA and anticonvulsant effects of MK-801. In the present study MK-801 is shown to be an extremely potent inhibitor of the binding of N-[3H](1-[2-thienyl]cyclohexy)piperidine) ([s3H]TCP to brain phencyclidine (PCP)/δ-receptors. It is IC5) value of 3.8 ± 0.8 nM in this assay ranks it as the most potent known ligand of brain PCP/δ-receptors. Addition of MK-801 altered the apparent Kd but not the apparent Bmax values for [3H]TCP binding, indicating a competitive interaction. The specificity of action of MK-801 is supported by the finding that MK-801 strongly inhibited the binding of (+)-N-[3H]allylnormetazocine ((+)-[3H]SKF 10.047) to the PCP/δ-receptor but its effect on (+)-[3H]SKF 10.047 binding to the non-PCP, haloperidol-sensitive δ-binding site was weaker by several orders of magnitude. Furthermore, MK-801 exerts PCP-like antagonistic effects upon NMDA-induced [3H]norepinephrine release. These findings support the concept that the anticonvulsant and anti-NMDA effects of MK-801 result from its being the most potent known ligand of PCP/δ-receptors.",
keywords = "(+)-[H]SKF 10,047 competition, Anticonvulsant, Haloperidol-sensitive non-PCP/δ-binding site, MK-801, N-Methyl-d-aspartate (NMDA)-stimulated [H]norepinephrine release, Phencyclidine (PCP)/δ-receptor, [H]TCP binding",
author = "Ratna Sircar and Michael Rappaport and Roxanne Nichtenhauser and Zukin, {Stephan R.}",
year = "1987",
month = "12",
day = "1",
doi = "10.1016/0006-8993(87)91606-4",
language = "English (US)",
volume = "435",
pages = "235--240",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - The novel anticonvulsant MK-801

T2 - a potent and specific ligand of the brain phencyclidine/gd-receptor

AU - Sircar, Ratna

AU - Rappaport, Michael

AU - Nichtenhauser, Roxanne

AU - Zukin, Stephan R.

PY - 1987/12/1

Y1 - 1987/12/1

N2 - MK-801 (5-methyl-10, 11-dihydro-5H-dibenzo[a,d]cyclohepten-5, 10-imine maleate) is a novel anticonvulsant agent reported to antagonize certain N-methyl-spd-aspartate (NMDA)-mediated effects non-competitively. The question arises of the mechanism underlying the anti-NMDA and anticonvulsant effects of MK-801. In the present study MK-801 is shown to be an extremely potent inhibitor of the binding of N-[3H](1-[2-thienyl]cyclohexy)piperidine) ([s3H]TCP to brain phencyclidine (PCP)/δ-receptors. It is IC5) value of 3.8 ± 0.8 nM in this assay ranks it as the most potent known ligand of brain PCP/δ-receptors. Addition of MK-801 altered the apparent Kd but not the apparent Bmax values for [3H]TCP binding, indicating a competitive interaction. The specificity of action of MK-801 is supported by the finding that MK-801 strongly inhibited the binding of (+)-N-[3H]allylnormetazocine ((+)-[3H]SKF 10.047) to the PCP/δ-receptor but its effect on (+)-[3H]SKF 10.047 binding to the non-PCP, haloperidol-sensitive δ-binding site was weaker by several orders of magnitude. Furthermore, MK-801 exerts PCP-like antagonistic effects upon NMDA-induced [3H]norepinephrine release. These findings support the concept that the anticonvulsant and anti-NMDA effects of MK-801 result from its being the most potent known ligand of PCP/δ-receptors.

AB - MK-801 (5-methyl-10, 11-dihydro-5H-dibenzo[a,d]cyclohepten-5, 10-imine maleate) is a novel anticonvulsant agent reported to antagonize certain N-methyl-spd-aspartate (NMDA)-mediated effects non-competitively. The question arises of the mechanism underlying the anti-NMDA and anticonvulsant effects of MK-801. In the present study MK-801 is shown to be an extremely potent inhibitor of the binding of N-[3H](1-[2-thienyl]cyclohexy)piperidine) ([s3H]TCP to brain phencyclidine (PCP)/δ-receptors. It is IC5) value of 3.8 ± 0.8 nM in this assay ranks it as the most potent known ligand of brain PCP/δ-receptors. Addition of MK-801 altered the apparent Kd but not the apparent Bmax values for [3H]TCP binding, indicating a competitive interaction. The specificity of action of MK-801 is supported by the finding that MK-801 strongly inhibited the binding of (+)-N-[3H]allylnormetazocine ((+)-[3H]SKF 10.047) to the PCP/δ-receptor but its effect on (+)-[3H]SKF 10.047 binding to the non-PCP, haloperidol-sensitive δ-binding site was weaker by several orders of magnitude. Furthermore, MK-801 exerts PCP-like antagonistic effects upon NMDA-induced [3H]norepinephrine release. These findings support the concept that the anticonvulsant and anti-NMDA effects of MK-801 result from its being the most potent known ligand of PCP/δ-receptors.

KW - (+)-[H]SKF 10,047 competition

KW - Anticonvulsant

KW - Haloperidol-sensitive non-PCP/δ-binding site

KW - MK-801

KW - N-Methyl-d-aspartate (NMDA)-stimulated [H]norepinephrine release

KW - Phencyclidine (PCP)/δ-receptor

KW - [H]TCP binding

UR - http://www.scopus.com/inward/record.url?scp=0023507325&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023507325&partnerID=8YFLogxK

U2 - 10.1016/0006-8993(87)91606-4

DO - 10.1016/0006-8993(87)91606-4

M3 - Article

C2 - 2827853

AN - SCOPUS:0023507325

VL - 435

SP - 235

EP - 240

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 1-2

ER -